AustarPharma, LLC
US H-1B Labor Condition Application activity for AustarPharma, LLC. Filed 62 disclosures between FY2010 and FY2024 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of AustarPharma, LLC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 91.9% |
| Denied | 8.1% |
Top occupations sponsored
SOC codes filed most by AustarPharma, LLC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 27 |
| 2 | 13-1041 | Compliance Officers | 11 |
| 3 | 13-2011 | Accountants and Auditors | 6 |
| 4 | 13-1151 | Training and Development Specialists | 3 |
| 5 | 19-1021 | Biochemists and Biophysicists | 2 |
| 6 | 15-2031 | Operations Research Analysts | 2 |
| 7 | 19-1029 | Biological Scientists, All Other | 2 |
| 8 | 13-1111 | Management Analysts | 2 |
| 9 | 15-1253 | Software Quality Assurance Analysts and Testers | 2 |
| 10 | 13-1161 | Market Research Analysts and Marketing Specialists | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 2 |
| FY2011 | 1 |
| FY2012 | 5 |
| FY2013 | 6 |
| FY2014 | 12 |
| FY2015 | 8 |
| FY2016 | 7 |
| FY2017 | 8 |
| FY2018 | 6 |
| FY2019 | 6 |
| FY2024 | 1 |
| Period | Value |
|---|---|
| FY2010 | 2 |
| FY2011 | 1 |
| FY2012 | 5 |
| FY2013 | 6 |
| FY2014 | 12 |
| FY2015 | 8 |
| FY2016 | 7 |
| FY2017 | 8 |
| FY2018 | 6 |
| FY2019 | 6 |
| FY2024 | 1 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.